Viewing Study NCT02950220


Ignite Creation Date: 2025-12-25 @ 4:10 AM
Ignite Modification Date: 2026-02-25 @ 4:52 AM
Study NCT ID: NCT02950220
Status: COMPLETED
Last Update Posted: 2019-07-30
First Post: 2016-10-28
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Pembrolizumab and Ibrutinib in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
Sponsor:
Organization: